Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Zachary Zimmerman

Premium

Arcturus Therapeutics has named Zachary Zimmerman as its chief business officer.

Zimmerman will be in charge of the company's corporate strategy, business development activities, and strategic relationships. He previously served as senior director of corporate development for Regulus Therapeutics and director of business development for Alnylam Pharmaceuticals.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.